Stock UniverseDerived research view · source repositories remain read-only

LB Pharmaceuticals Inc (LBRX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
30.85
Global Rank
1837
Market Cap
607.43M
Latest Close
28.53
RS Composite
13.98% · G#605

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-10.84%
3M
19.97%
6M
52.08%
1Y
64.91%
3Y
64.91%
5Y
64.91%
10Y
64.91%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 155.75K · 30-day average: 158.66K · Max drawdown over stored range: -17.82%

Research Snapshot

Relative Strength vs SPX

RS Composite13.98%
20D RS-11.42%
60D RS6.63%
120D RS34.03%
Global RS Rank605 · 81.97% percentile
Watch+Speculative RS Rank370 · 82.36% percentile
Group ScopeWatch+Speculative
Primary RS Rank79 · 82.75% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank251 / 701
Primary Percentile64.34
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for LBRX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2022FY 2023FY 2024FY 2025
Revenue
Revenue Growth (YoY)
Gross Profit
Operating Income-2.809-11.376-64.83-29.504
Free Cash Flow-2.728-12.119-53.821-35.26
Free Cash Flow Per Share-11.805-48.552-213.754-4.383
EPS (Diluted) GAAP-62.091319-25.139519-250.614601-3.132945
EPS Growth
EPS Non-GAAP
Gross Margin
Operating Margin
Profit Margin
Free Cash Flow Margin
Shares Outstanding (Diluted)0.23110.24960.25188.0451
Shares Change (YoY)4200%8.018%0.874%2145.811%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-12n/an/an/an/a-19.05Mn/a-0.6728.24M365.64Mn/aprocessed
2025 Q42026-03-26n/an/an/an/a-11.47Mn/a-0.4525.59M295.21Mn/aprocessed
2025 Q32025-11-06n/an/an/an/a-3.56Mn/a-0.615.81M314.48Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.